Recent Events & Catalysts
Royalty Pharma plc (RPRX) — real, dated facts. Not a claim about what caused any single day's price move.
Committee Signals
Proprietary signals generated by the Innellis AI committee — score changes, rating shifts, and analyst disagreements.
No committee signals recorded yet.
News
Dividend Champion, Contender, And Challenger Highlights: Week Of August 9
SeekingAlpha · 4d ago
JP Morgan Maintains Overweight on Royalty Pharma, Raises Price Target to $62
Benzinga · 4d ago
Teva Pharmaceuticals: Continuing To Execute On Its 'Pivot To Growth' Plan
SeekingAlpha · 6d ago
Royalty Pharma (NASDAQ:RPRX) Beats Q2 Revenue Estimates, Raises Full-Year Guidance
ChartMill · 6d ago
Royalty Pharma plc (RPRX) Q2 2026 Earnings Call Transcript
SeekingAlpha · 6d ago
Royalty Pharma plc 2026 Q2 - Results - Earnings Call Presentation
SeekingAlpha · 6d ago
Royalty Pharma Q2 Adj. EPS $1.32 Beats $1.28 Estimate, Sales $674.000M Miss $693.190M Estimate
Benzinga · 6d ago
Royalty Pharma: At The Right P/E, I'm In (But Not Here)
SeekingAlpha · 6d ago
SEC Filings (90 days)
Results of operations (earnings release), Financial statements and exhibits
Filed 2026-08-05 · 6d ago · Material
Submission of matters to a vote of security holders
Filed 2026-06-04 · 68d ago
Entry into a material agreement, Creation of a direct financial obligation (new debt), Financial statements and exhibits
Filed 2026-05-28 · 75d ago
Earnings
No recent earnings data available.
Latest Analyst Action
No recent analyst actions available.